Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 9, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions
EndometriosisImmunityMicrobiota
Interventions
PROCEDURE

surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines

The surgery is performed on both arms as part of the current / recommended treatment. But during this surgery, an extension of the samples is performed. In both arms, the surgeons take samples of the endometrium, peritoneum and peritoneal lavage. For patients with endometriosis, the lesion is also sampled.

BIOLOGICAL

Blood test

Before surgery, the patient will need a blood test at the recommendation of the anaesthetist. This allows us to see the level of oestrogen and progesterone in the blood.

BIOLOGICAL

Stool samples

Before the surgery, the patient will take a stool sample.

BIOLOGICAL

Stool samples

After 1 year's follow-up, the patient will take a stool sample.

Trial Locations (1)

38000

CHUGA, Grenoble

All Listed Sponsors
collaborator

Etablissement Français du Sang

OTHER

lead

University Hospital, Grenoble

OTHER

NCT07078435 - Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis | Biotech Hunter | Biotech Hunter